2.5 Distance map derived loss penalty term 3.基于区域的损失函数 3.1 Dice Loss 3.2 Generalized Dice loss(存疑) 3.3 Tversky Loss 3.4 Focal Tversky Loss 3.5 Sensitivity Specificity Loss(存疑) 3.6 Log-Cosh Dice Loss 3.7 Lovasz-Softmax Loss 4.基于边界的损失函数 4.1 Shape-aware Loss 4.2 Hausdorff ...
Moltz Contour Dice coefficient (CDC) Loss: Learning a Loss Function for Segmentation: A Feasibility Study ISBI 202003 Suprosanna Shit clDice -- a Topology-Preserving Loss Function for Tubular Structure Segmentation (pytorch) arXiv 202002 TBD Uncertainty-weighted Loss: Function for Medical Image ...
The vast majority of novel candidate drugs that enter clinical testing fail to demonstrate sufficient safety and efficacy to gain regulatory approval. This is largely due to poor predictive value of preclinical models of disease along with a lack of knowledge about the long-term consequences of targ...
The genetic analysis revealed a rare homozygous loss of function variant (NM_000685.5; c.415C > T; p.Arg139*) in the Angiotensin II Receptor Type 1 (AGTR1) gene. Conclusion This case highlights the consequence of loss-of-function variants in AGTR1 gene leading to RTD, which is ...
Fig. 2: Age trend in BMD forMEPELoF mutation carriers. In this figure we have compared the forearm bone mineral density (BMD) in theMEPEloss-of-function (LoF) mutation, p.Lys70IlefsTer26, carriers (dotted lines) compared to non-carriers (solid lines) in the HUNT dataset (N = 19...
Novel loss-of-function variants in TRIO are associated with neurodevelopmental disorder: case report Laura Schultz-Rogers, Karthik Muthusamy, Filippo Pinto e Vairo, Eric W. Klee & Brendan Lanpher BMC Medical Genetics volume 21, Article number: 219 (2020) Cite this article 6387 Accesses 5 Cita...
This demonstrated that the benefit with ticagrelor over clopidogrel was predominately present in the short term, which may be related to the fast action of ticagrelor. Nevertheless, numerical benefit and no evidence of harm were observed in the second and third weeks of treatment, although the ...
Adults: Approved to be used with diet and exercise for long-term weight management in adults with obesity (BMI ≥30 kg/m2) or overweight (BMI ≥27 kg/m2), in the presence of at least one weight-related medical condition (such as high blood pressure, type 2 diabetes, or elevated ...
Human genetic variants predicted to cause loss-of-function of protein-coding genes (pLoF variants) provide natural in vivo models of human gene inactivation and can be valuable indicators of gene function and the potential toxicity of therapeutic inhibit
Journal of the American Medical Association (JAMA). Long-term drug treatment for obesity: A systematic and clinical review. 2014; 311(1):74–86 U.S. Food and Drug Administration. Beware of Fraudulent Weight-Loss 'Dietary Supplements'. Accessed Nov. 18, 2024 at https://www.drugs.com/fda-...